Treatment of fused bovine satellite cell (Bsc) cultures with trenbolone acetate (TBA), a testosterone analog, results in increases in protein synthesis and decreases in protein degradation (Kamanga-Sollo et Active G protein-coupled receptors (Gpcr), matrix metalloproteinases 2/9 (mmp2/9), heparin-binding epidermal growth factor (hbeGF), epidermal growth factor receptor (eGFr), erbB2, and insulin-like growth factor 1 receptor (iGF-1r) are necessary for trenbolone acetateinduced alterations in protein turnover rate of fused bovine satellite cell cultures 1
ABsTrAcT: Trenbolone acetate (TBA), a testosterone analog, increases protein synthesis and decreases protein degradation in fused bovine satellite cell (BSC) cultures. However, the mechanism through which TBA alters these processes remains unknown. Recent studies indicate that androgens improve rate and extent of muscle growth through a nongenomic mechanism involving G protein-coupled receptors (GPCR), matrix metalloproteinases (MMP), heparin-binding epidermal growth factor (hbEGF), the epidermal growth factor receptor (EGFR), erbB2, and the insulin-like growth factor-1 receptor (IGF-1R). We hypothesized that TBA activates GPCR, resulting in activation of MMP2/9 that releases hbEGF, which activates the EGFR and/or erbB2. To determine whether the proposed nongenomic pathway is involved in TBA-mediated alterations in protein turnover, fused BSC cultures were treated with TBA in the presence or absence of inhibitors for GPCR, MMP2/9, hbEGF, EGFR, erbB2, or IGF-1R, and resultant protein synthesis and degradation rates were analyzed. Assays were replicated at least 9 times for each inhibitor experiment utilizing BSC cultures obtained from at least 3 different steers that had no previous exposure to steroid compounds. As expected, fused BSC cultures treated with 10 nM TBA exhibited increased (P < 0.05) protein synthesis rates and decreased (P < 0.05) protein degradation rates when compared to control cultures. Treatment of fused BSC cultures with 10 nM TBA in the presence of inhibitors for GPCR, MMP2/9, hbEGF, EGFR, erbB2, or IGF-1R suppressed (P < 0.05) TBA-mediated increases in protein synthesis rate. Alternatively, inhibition of GPCR, MMP2/9, hbEGF, EGFR, erbB2, or IGF-1R in the presence of 10 nM TBA each had no (P > 0.05) effect on TBA-mediated decreases in protein degradation. However, inhibition of both EGFR and erbB2 in the presence of 10 nM TBA resulted in decreased (P < 0.05) ability of TBA to decrease protein degradation rate. Additionally, fused BSC cultures treated with 10 nM TBA exhibit increased (P < 0.05) pAKT protein levels. These data indicate the TBA-mediated increases in protein synthesis likely involve GPCR, MMP2/9, hbEGF, EGFR, erbB2, and IGF-1R. However, the mechanism through which TBA mediates changes in protein degradation is different and appears to involve only the EGFR and erbB2. Furthermore, it appears the protein kinase B pathway is involved in TBA's effects on fused BSC cultures.
al., 2011). The androgen receptor (Ar; Sinha-Hikim et al., 2002; Kamanga-Sollo et al., 2008) and the insulinlike growth factor 1 receptor (iGF-1r; Kamanga-Sollo et al., 2008) are known to be involved in these processes; however, recent studies demonstrate that androgens also may increase muscle growth through activation of G protein-coupled receptors (Gpcr; Heinlein and Chang, 2002; Estrada et al., 2003) . The epidermal growth factor (eGF) receptor (eGFr) and erbB2 have also been linked to testosterone-mediated increases in muscle growth (Estrada et al., 2003; Natoli et al., 2005; Marqueti et al., 2006; Zhu and Kyprianou, 2008; Fu et al., 2012; Montarras et al., 2013) . Additionally, recent research indicates that TBA-enhanced proliferation of cultured BSC requires active GPCR, matrix metalloproteinases (mmp), heparin-binding EGF (hbeGF), EGFR, erbB2, and IGF-1R (Thornton et al., 2015) . In addition, TBA is known to function through the protein kinase b (AKT) pathway (Dubois et al., 2012) . Consequently, to further understand the mechanism through which androgenic compounds are able to increase growth of bovine skeletal muscle cells, we have utilized inhibitors to determine the necessity for active GPCR, MMP2/9, hbEGF, EGFR, erbB2, and IGF-1R in TBA-mediated increases in protein synthesis rates and decreases in protein degradation rates in fused BSC cultures. Additionally, we have assessed the effect of TBA treatment on pAKT level in fused BSC cultures.
mATeriALs AND meTHoDs

Bovine Satellite Cell Isolation
Isolation of bovine satellite cells was completed as previously described (Hathaway et al., 1991 (Hathaway et al., , 1994 Frey et al., 1995) . Yearling steers that had never been implanted with androgenic or estrogenic compounds were euthanized using procedures approved by the University of Minnesota Institutional Animal Care and Use Committee. Approximately 1 kg of the semimembranosus muscle was dissected from the animal and transported to the cell culture laboratory using sterile techniques. All subsequent procedures were conducted in a sterile field within a tissue culture hood. Connective tissue and adipose were removed from the muscle, at which point the muscle was ground utilizing a sterile meat grinder. The ground muscle was incubated in 0.1% pronase in Earl's balanced salt solution for 1 h at 37°C and mixed every 10 min. The pellet was then strifuged at 1,500 × g for 4 min at room temperature (rT), the resultant pellet was suspended in PBS (140 mM NaCl, 1 mM KH 2 PO 4 , 3 mM KCl, 8 mM Na 2 HPO 4 , pH 7.4), and the suspension was centrifuged at 500 × g for 10 min at RT. The supernatant recovered from the previous spin was then centrifuged at 1,500 × g for 10 min at RT to pellet the mononucleated cells. The PBS wash and differential centrifugation were repeated 2 more times. The resulting mononucleated cell preparation was suspended in cold (4°C) Dulbecco's modified eagle medium (Dmem) containing 10% fetal bovine serum (FBs) and 10% (vol/vol) dimethyl sulfoxide (Dmso) and frozen. Cells were stored in liquid nitrogen for subsequent use. Clonal analysis of satellite cell cultures established from these preparations showed that between 80% and 90% of the cells were able to establish colonies that contained fusion, indicating that between 80% and 90% of the cells in the preparations were myogenic.
Bovine Satellite Cell Culture
Bovine satellite cell preparations were plated on 4-cm 2 culture dishes precoated with reduced growth factor basement membrane Matrigel (Corning, Tewksbury, MA) diluted 1:50 (vol/vol) with DMEM as described previously (Johnson et al., 1998) . Media used in this study did not contain phenol red unless otherwise indicated. Plating density was empirically established so that all cultures were approximately 90% confluent after 96 h in culture. Cells were plated in DMEM containing 10% FBS and incubated at 37°C, 5% CO 2 in a water-saturated environment. Cultures were rinsed once with DMEM and fed at 72 h with DMEM containing 10% FBS. At 96 h, cultures were fed with a fusionpromoting medium that consisted of DMEM with 3% horse serum and 1.5 mg BSA-linoleic acid/mL. After 120 h in culture, cytosine arabinoside (final concentration 10 −6 M) was added to the culture media. Fusion percentage at 144 h was typically 75%-80%.
Determination of Protein Synthesis Rate
Determination of protein synthesis rate in fused BSC cultures was conducted as described previously ( Kamanga-Sollo et al., 2010) . Briefly, at 144 h in culture, fused BSC cultures established as described above were rinsed and treated in serum-free medium (sFm; DMEM containing 250 μg IGFBP-3-free fetuin/ mL, 100 μg BSA-linoleic acid/mL [Sigma, St. Louis, MO, and 10 −9 M insulin). Fused cultures were treated with various inhibitors, growth factors, or hormones as described below. After 3 h of incubation in treatment media, 3 μCi of 3 H-phenylalanine were added to each culture, and incubation was continued for an additional 3 h. After this incubation period, the medium was removed, and cells were incubated overnight at 4°C in 5% trichloroacetic acid (TcA). Cells were then washed once with 5% TCA and lysed with 1 N NaOH containing 1% Triton X-100. Protein concentration was deter-mined using the Pierce BSA Protein Assay Kit (Thermo Scientific, Waltham, MA), and 3 H-phenylalanine was measured by counting an aliquot of the cell lysate in a scintillation counter. For each individual assay, protein synthesis rate was calculated as 3 H-phenylalanine incorporation per milligram of protein for each well. Each assay contained triplicate determinations that were averaged for subsequent statistical analyses.
Determination of Protein Degradation Rate
Protein degradation rates in fused BSC cultures were determined as described previously (Kamanga-Sollo et al., 2010) . At 120 h in culture, BSC cultures established as described above were labeled for 24 h with 3 μCi of 3 H-phenylalanine. At 144 h, the label was removed, and cells were subjected to a 4-h chase in DMEM containing 1% IGFBP-3-free swine serum (sss; SSS was prepared by passing sera obtained from 6-wk-old male pigs castrated within 1 wk of birth through an IGFBP-3 immunoaffinity column [Kamanga−Sollo et al., 2004] and 2 nM cold phenylalanine). At the end of this incubation the chase medium was removed, and cultures were washed once with DMEM and treated with inhibitors and/or growth factors or TBA as described below. Cultures were incubated in the test medium for 24 h. At the end of this incubation period, the medium was quantitatively removed from the cells, and an equal amount of 20% TCA was added to give a final concentration of 10% TCA; this mixture was then stored at 4°C overnight. The TCA-insoluble vs. TCA-soluble materials from the medium were separated by centrifuging the mixture at 1,500 × g for 25 min at 4°C. After the centrifugation, the TCA-soluble supernatant was transferred directly into a scintillation vial containing 10 mL EcoLite scintillation fluid (MP Biomedicals, Santa Ana, CA), and the pellet was solubilized in 1 N NaOH/1% Triton X-100 by heating at 42°C for 30 min with subsequent transfer to a scintillation vial containing 10 mL EcoLite scintillation fluid (MP Biomedicals). Cellular material was solubilized in 600 μL 1 N NaOH/1% Triton X-100 and heated at 42°C for 30 min. This cellular material was then transferred to a scintillation vial containing 10 mL of EcoLite scintillation fluid (MP Biomedicals). The scintillation vials each containing the cellular material, TCA-soluble medium, and TCA-insoluble medium were read on a scintillation counter. Percentage protein degradation was calculated as (TCA soluble medium counts/total TCA-soluble, TCA-insoluble, and cellular material counts) × 100 in each well. All individual experiments contained triplicate determinations. Each assay contained triplicate determinations that were averaged for subsequent statistical analyses.
Inhibitor Assays
Six different inhibitors were utilized to determine the effect of inhibiting GPCR, MMP2/9, hbEGF, erbB2, EGFR, and IGF-1R on TBA-mediated increases in protein synthesis and decreases in protein degradation in fused BSC cultures. Inhibition of GPCR was performed using guanosine 5′-O-2-thiodiphosphate (GDpβs; Calbiochem, Billerica, MA) as previously described at a concentration of 100 nM (Estrada et al., 2003; Fu et al., 2012) . Briefly, fusion media were removed at 144 h in protein synthesis assays and chase media were removed at 148 h in protein degradation assays, and cultures were placed in assay respective treatment media ± 100 nM GDPβS for 30 min. Following this 30-min incubation period, media were removed, and BSC cultures were placed in new treatment media ± 100 nM GDPβS with appropriate additions of 25 ng long arginine 3 insulin-like growth factor 1 (Lr3-iGF-1; an IGF-1 analog that binds normally to the IGF-1R but has little or no affinity for IGF-binding proteins [Francis et al., 1992] ; GroPep Bioreagents Pty Ltd, Thebarton, SA, Australia), hbEGF (R&D Systems, Minneapolis, MN), or 10 nM TBA (Steraloids Inc., Newport, RI).
Matrix metalloproteinases 2/9 inhibition was performed using an MMP2/9 inhibitor (mmpi; MMP-2/ MMP-9 inhibitor II; Calbiochem, Billerica, MA) following previously described methods at a concentration of 10 µM . Briefly, fusion media were removed at 144 h in protein synthesis assays, and chase media were removed at 148 h in protein degradation assays. Cultures were then washed once with warm DMEM, and cultures were incubated in assay respective treatment media ± 10 µM MMPI for 30 min. Following the 30-min incubation period, media were removed, and new treatment media ± 10 µM MMPI and containing 25 ng LR3-IGF-1/mL or 10 nM TBA were added to cultures.
Analysis of the role of hbEGF was performed using CRM197 (Sigma Aldrich, St. Louis, Mo), a potent antagonist of hbEGF using previously described methods at a concentration of 1 μg/mL . Briefly, fusion media were removed at 144 h in protein synthesis assays, and chase media were removed at 148 h in protein degradation assays. Cultures were then washed once with warm DMEM and incubated with assay respective treatment media ± 1 μg CRM197/ mL for 30 min. Following the 30-min incubation period, media were removed, and new treatment media ± 1 μg CRM197/mL containing 25 ng LR3-IGF-1/mL, 5 ng hbEGF/mL, or 10 nM TBA were added to cultures.
Inhibition of the EGFR and erbB2 was completed using AG1478 (Calbiochem), an EGFR tyrosine kinase inhibitor, and AG879 (Calbiochem), an erbB2 tyrosine kinase inhibitor, as previously described at concentrations of 1 μM for each respective inhibitor (Zhou and Brattain, 2005; Reiter et al., 2014) . Briefly, fusion media were removed at 144 h in protein synthesis assays, and chase media were removed at 148 h in protein degradation assays. Cells were washed once with warm DMEM, and cultures were incubated in assay respective treatment media ± 1μM AG1478 and/or 1µM AG879 for 30 min. Following the 30-min incubation period, media were removed, and cultures received new treatment media ± 1 μM AG1478 and/or 1 μM AG879 containing 5 ng hbEGF/mL or 10 nM TBA.
Inhibition of the IGF-1R was performed using an IGF-1R tyrosine kinase inhibitor (AG1024; Calbiochem) as preciously described at a concentration of 1 µM (Kamanga-Sollo et al., 2013) . Briefly, fusion media was removed at 144 h in protein synthesis assays and chase media was removed at 148 h in protein degradation assays. Cultures were then washed once with warm DMEM and incubated in assay respective treatment media ± 1µM AG1024 for 30 min. Following the 30-min incubation period, media were removed, and cultures were placed in fresh treatment media ± 1 µM AG1024 containing 25 ng LR3-IGF-1/ mL, 5 ng hbEGF/mL, or 10 nM TBA.
Trenbolone acetate was initially dissolved in 95% ethanol; GDPβS and CRM197 were dissolved in cell culture grade water; and MMPI, AG1478, AG879, and AG1024 were dissolved in DMSO. All cultures, including the control, contained a final concentration of 0.1% (vol/vol) ethanol and 0.1% DMSO (vol/vol) in assays containing MMPI, AG1478, AG879, and AG1024. The concentrations of ethanol and DMSO added to the cultures did not affect proliferation rate (data not shown). Concentrations for TBA, hbEGF, and LR3-IGF-1 were determined following previously published methods (Francis et al., 1992; Kamanga-Sollo et al., 2011; Reiter et al., 2014) . All assays contained triplicate measurements for each inhibitor assayed. Cells isolated from a minimum of 3 separate steers were utilized, and cells from each steer were used in 3 separate assays to assess the effects of each inhibitor. This means that each of the assays was performed at least 9 times for each different inhibitor utilized.
Western Blot Analysis of pAKT
Cultures were grown and induced to fuse as described above. At 144 h in culture, media were removed, and cells were washed once with DMEM and then placed in fresh DMEM for 30 min. After this 30-min suppression period, previous media were removed, and fresh DMEM containing either no treatment, 10 nM TBA, 5ng/ mL hbEGF, or 25ng/mL LR3-IGF-I was added to each culture for 30 min. Culture plates were then immediately placed on blue ice, rinsed once with PBS, and lysed in a total protein extraction buffer: 50 mM Tris-HCl (pH 8.0), 150 mM NaCl, 1 mM ethylenediaminetetraacetic, 1 mM sodium fluoride, 1 mM polymethanesulfonyl fluoride, 1 mM sodium orthovanadate, and 1% Nonidet p-40. Seventy-five microliters of extraction buffer were used to pool cellular material from three 2-cm 2 culture wells. The samples were then centrifuged at 10,000 × g for 10 min at 4°C, and the supernatant was removed and stored at −80°C. Total protein was quantified using the Pierce BSA Protein Assay Kit (Thermo Scientific) on a BioTek Synergy 2 plate reader (BioTek, Winooski, VT). Samples were electrophoresed on 10% SDS polyacrylamide gels and then electrophoretically transferred to a nitrocellulose membrane. pAKT was detected by incubation of the membrane overnight at 4°C with an anti-pAKT antibody (1:1,000 dilution in TBS with 0.05% Tween 20
[TBsT] containing 5% nonfat dried milk; Cell Signaling, Danvers, MA, catalog number 9271). The membrane was then rinsed 6 times for 5 min each in TBST, after which time the membrane was incubated for 1 h at RT with horseradish peroxidase-conjugated goat anti-rabbit IgG (Cell Signaling, catalog number 7074) diluted 1:2,000. Membranes were then washed in TBST another 6 times for 5 min each and then placed in Western Sure Premium Chemiluminescent Substrate (LI-COR, Lincoln, NE) and read on the C-Digit blot scanner (LI-COR) using high sensitivity. Blots were then stripped using Restore Western Blot stripping buffer (Thermo Fisher Scientific, Grand Island, NY) as per the manufacturer's protocol and blotted for tubulin. Membranes were blotted as described above; in brief, membranes were incubated with an anti-tubulin antibody (Cell Signaling, catalog number 2128) at a dilution of 1:2,000 in TBST + 5% BSA overnight at 4°C. Membranes were then washed in TBST 6 times for 5 min each and incubated for 1 h in at RT with HRP-conjugated goat anti-rabbit IgG (Cell Signaling, catalog number 7074) diluted 1:4,000. Membranes were then washed in TBST another 6 times for 5 min each and then placed in Western Sure Premium Chemiluminescent Substrate (LI-COR) and read on the C-Digit blot scanner (LI-COR). All Western blot data obtained for pAKT expression were normalized to tubulin expression values.
Statistical Analysis
Statistical analysis was completed using the MIXED procedure of SAS (version 9.4; SAS Inst. Inc., Cary, NC). All data are presented as the least squares mean ± SEM. Data from multiple assays performed on cells isolated from different animals were combined. Preliminary analyses indicated that there were no effects (P > 0.05) observed for either the assay number or the different animals, and as such, these 2 factors were included as random variables in the model. The model included treatment as a fixed effect and assay number and the animal the BSC were isolated from as random effects. When treatment differences were found to be significant (P < 0.05), least squares means were separated using TukeyKramer adjustments (P < 0.05). This analysis was performed for data obtained from protein synthesis assays, protein degradation assays, and Western blot analyses.
resuLTs
Effect of Inhibiting GPCR on TBA-Stimulated Increases in Protein Synthesis Rate of Fused BSC Cultures
Protein synthesis rates in fused BSC cultures were increased (P < 0.05) in cultures treated with either TBA or LR3-IGF-1 when compared to SFM control cultures (Fig. 1, 2, 3, 4, 5) . Treatment of fused BSC cultures with GDPβS decreased (P < 0.05) TBA-mediated increases in protein synthesis rate (Fig. 1) , indicating that GPCR are involved in the mechanism through which TBA increases protein synthesis in fused BSC cultures. To ensure that GDPβS was not indiscriminately inhibiting protein synthesis, the effect of GPCR inhibition in the presence of LR3-IGF-1 also was assessed. In the presence of GDPβS, fused BSC cultures treated with LR3-IGF-1 exhibit the same increase in protein synthesis rate that is observed in LR3-IGF-1-treated cultures that did not receive GDPβS treatment (P > 0.05; Fig. 1 ). This confirms that GDPβS is not nonspecifically inhibiting protein synthesis.
Effect of Inhibiting MMP2/9 on TBA-Stimulated Increases in Protein Synthesis Rate of Fused BSC Cultures
Fused BSC cultures treated with TBA, hbEGF, or LR3-IGF-1 displayed increases (P < 0.05) in protein synthesis rates compared to control cultures (Fig. 2, 3 , 4, 5). In the presence of MMPI, BSC cultures treated with TBA, hbEGF, or LR3-IGF-1 show no increase (P < 0.05) in protein synthesis rates when compared to control cultures. These data indicate that MMP2/9 are involved in TBA-mediated increases in protein synthesis rate of fused BSC cultures. However, the fact that MMPI also inhibited the ability of hbEGF and LR3-IGF-1 to stimulate increases in protein synthesis rates indicates that inhibition of MMP2/9 is not specifically responsible for TBA-mediated increases in protein synthesis rates. Figure 1 . Effect of inhibition of G protein-coupled receptors using 100 nM guanosine 5′-O-2-thiodiphosphate (GDPβS) on trenbolone acetate (TBA) or 25 ng/mL long arginine 3 insulin-like growth factor-1 (LR3-IGF-1) induced alterations in protein synthesis rate in fused bovine satellite cell cultures. After 144 h, cultures were treated with serum-free medium (SFM) or with SFM plus 10 nM TBA, 25 ng/mL LR3-IGF-1, and/ or GDPβS. Protein synthesis rates were determined as described in the Materials and Methods section and were initially expressed as trichloroacetic acid-insoluble CPM per milligram of protein. To facilitate pooling multiple assays for statistical analysis, data from individual assays were normalized to the synthesis rate in SFM-treated cultures (control) for each assay. Triplicate determinations were averaged for each assay, and each assay was completed a total of 5 times, with each assay utilizing satellite cells obtained from 4 different animals to yield the provided data. Bars containing no letters in common are statistically different (P < 0.01).
Figure 2. Effect of inhibition of matrix metalloproteinases 2/9
(MMP2/9) using 10 µM of a MMP2/9 inhibitor (MMPI) on trenbolone acetate (TBA), heparin-binding epidermal growth factor (hbEGF), or long arginine 3 insulin-like growth factor-1 (LR3-IGF-1) induced alterations in protein synthesis rate in fused bovine satellite cell cultures. After 144 h, cultures were treated with serum-free medium (SFM) or with SFM plus 10 nM TBA, 5 ng/mL hbEGF, 25 ng/mL LR3-IGF-1, and/or MMPI. Protein synthesis rates were determined as described in the Materials and Methods section and were initially expressed as trichloroacetic acid-insoluble CPM per milligram of protein. To facilitate pooling multiple assays for statistical analysis, data from individual assays were normalized to the synthesis rate in SFM-treated cultures (control) for each assay. Triplicate determinations were averaged for each assay, and each assay was completed a total of 6 times. Assays were performed utilizing cells isolated from 5 different animals. Bars containing no letters in common are statistically different (P < 0.01).
Effect of Inhibiting hbEGF on TBA-Stimulated Increases in Protein Synthesis Rate of Fused BSC Cultures
As expected, treatment of fused BSC cultures with CRM197 inhibited (P < 0.05) hbEGF-stimulated increases in protein synthesis rate (Fig. 3) . Inhibition of hbEGF with CRM197 also inhibited (P < 0.05) TBAmediated increases in protein synthesis rate in fused BSC cultures (Fig. 3) . In contrast, LR3-IGF-1-treated cultures also treated with CRM197 had no (P > 0.05) effect on the ability of LR3-IGF-1 to stimulate protein synthesis rate, indicating that inhibiting hbEGF activity with CRM197 does not lead to a general inhibitory effect on protein synthesis rate in fused BSC cultures. (Fig. 3) .
Effect of Inhibiting EGFR and erbB2 on TBA-Stimulated Increases in Protein Synthesis Rate of Fused BSC Cultures
Fused BSC cultures treated with AG879 and/or AG1478 displayed suppressed (P < 0.01) TBA-, hbE-GF-, and LR3-IGF-1-mediated increases in protein synthesis rate (Fig. 4) . These data show that the EGF and the erbB2 receptors play a role in the mechanism through which both TBA and LR3-IGF-1 increase protein synthesis rate in fused BSC cultures. On the basis of these results, it appears that both receptors are required since inhibition of either of them independently or of both of them simultaneously decreases TBA-mediated increases in protein synthesis rate in fused BSC cultures.
Effect of Inhibiting IGF-1R on TBA-Stimulated Increases in Protein Synthesis Rate of Fused BSC Cultures
Treatment of BSC cultures with AG1024 suppressed (P < 0.05) both TBA-and LR3-IGF-1-mediated increases in protein synthesis rate of fused BSC cultures (Fig. 5) . These data indicate that the IGF-1R is involved in the mechanism through which TBA acts to increase protein accretion in myotubes. Treatment of cultures with AG1024 had no effect (P > 0.05) on hbEGF-mediated increases in protein synthesis rate, suggesting that AG1024 is not a nonspecific inhibitor of protein synthesis in the presence of mitogenic stimuli (Fig. 5) .
Effect of Inhibitors on TBA-Stimulated Decreases in Protein Degradation Rate of Fused BSC Cultures
Inhibition of GPCR, MMP2/9, hbEGF, or IGF-1R had no effect (P > 0.05) on the ability of TBA to modulate decreases in protein degradation rate of fused BSC cultures (data not shown). Additionally, inhibition of either the EGFR or erbB2 had no effect (P > 0.05) on TBA-or hbEGF-mediated decreases in protein degradation rate of fused BSC cultures (Fig. 6) . However, when both the EGFR and the erbB2 were inhibited, neither TBA nor hbEGF was able to significantly (P > 0.05) decrease protein degradation rate when compared to the control (Fig. 6) . These data suggest either that both the EGFR and erbB2 are necessary for TBA-mediated decreases in protein degradation rate in fused myotubes or that the 2 receptors have redundant functions so that if either receptor is functioning, TBA-mediated decreases in protein degradation will occur. In the presence of AG1478 and/or AG879, LR3-IGF-1-mediated decreases (P < 0.05) in protein degradation rates were observed (Fig. 6) , indicating that AG879 and AG1478 are not nonspecific in their ability to affect protein degradation rate in fused BSC cultures. Effect of inhibition of heparin-binding epidermal growth factor (hbEGF) using 1 µg/mL of an hbEGF inhibitor (CRM197) on trenbolone acetate (TBA), hbEGF, or long arginine 3 insulin-like growth factor-1 (LR3-IGF-1) induced alterations in protein synthesis rate in fused bovine satellite cell cultures. After 144 h, cultures were treated with serum-free medium (SFM) or with SFM plus 10 nM TBA, 5 ng/mL hbEGF, 25 ng/mL LR3-IGF-1, and/or MMPI. Protein synthesis rates were determined as described in the Materials and Methods section and were initially expressed as trichloroacetic acid-insoluble CPM per milligram of protein.
To facilitate pooling multiple assays for statistical analysis, data from individual assays were normalized to the synthesis rate in SFM-treated cultures (control) for each assay. Triplicate determinations were averaged for each assay, and each assay was completed a total of 5 times. Assays were performed utilizing cells isolated from 5 different animals. Bars containing no letters in common are statistically different (P < 0.01).
Changes in pAKT Protein Expression in Fused BSC Cultures after TBA Treatment
Fused BSC cultures treated with TBA, hbEGF, or LR3-IGF-1 for 30 min exhibit increases (P < 0.05) in pAKT protein level when compared to control cultures receiving no treatment (Fig. 7) . Matching protein synthesis assays were completed in conjunction with the Western blot analyses to ensure that TBA, hbEGF, and LR3-IGF-1 demonstrated increases in protein synthesis rate (data not shown). These data indicate that TBA treatment activates the AKT pathway in BSC myotubes.
DiscussioN
Implanting beef cattle during the feedlot phase has been shown to increase ADG 18%, muscle growth 10% to 30%, feed intake 6%, feed efficiency 5% to 15%, carcass weight 5%, carcass leanness 5% to 8%, and rib eye area 4% when compared to nonimplanted controls (Duckett et al., 1996; Beermann, 2012; Duckett and Pratt, 2014) . In addition, a recent review article states that with current beef prices, provision of a combination implant increases returns $163 per animal (Duckett and Pratt, 2014) . Currently, there is no consensus regarding the cellular mechanism(s) through which either TBA or estradiol (e2) is responsible for improving postnatal muscle growth and resultant profitability for the producer. Thus, it is imperative that these mechanisms be further elucidated to aid in the development of strategies to further improve beef production practices.
Combination implants, containing both androgens and estrogens, are most effective in enhancing growth of beef cattle when compared to growth of cattle receiving an implant with either steroid alone (Hayden et al., 1993; Johnson et al., 1996; Dayton and White, 2014) . In fact, steers implanted with a combined E2 and TBA implant produce BSC cultures with significantly higher proliferation rates when compared to BSC cultures from nonimplanted steers (Johnson et al., 1996) . However, the mechanism for each compound needs to be determined before attempting to determine the mechanism of the combined compound. TBA has been shown to have greater relative androgenic and anabolic activity of 3 to 5 and 5 to 8 times higher, respectively, when compared to testosterone (Bouffault and Willemart, 1983) . TBA treatment increases protein synthesis rate and decreases protein degradation rate in fused BSC cultures (Kamanga-Sollo et al., 2008; Kamanga-Sollo et al., 2011) . Additional studies conducted in both humans and animals indicate that testosterone increases muscle fiber diameter, number of nuclei present in muscle fibers, absolute number of satellite cells, and percentage of satellite cells relative to myofiber nuclei present in the muscle (Bhasin et al., 2001; Sinha-Hikim et al., 2002; Sinha-Hikim et al., 2003) . However, the mechanism through which testosterone and its analogs are able to improve growth of skeletal muscle remains unclear.
The genomic actions of testosterone have been well characterized; the AR acts as a ligand inducible transcription factor responsible for augmenting transcription Figure 4 . Effect of inhibition of the epidermal growth factor receptor (EGFR) using a specific tyrosine kinase inhibitor, AG1478, and/or inhibition of the erbB2 receptor using a specific tyrosine kinase inhibitor, AG879, on trenbolone acetate (TBA), heparin-binding epidermal growth factor (hbEGF), or long arginine 3 insulin-like growth factor-1 (LR3-IGF-1) induced alterations in protein synthesis rate in fused bovine satellite cell cultures. After 144 h, cultures were treated with serum-free medium (SFM) or with SFM plus 10 nM TBA, 5 ng/mL hbEGF, 25 ng/mL LR3-IGF-1, and/or 1 µM AG1478 and/or 1 µM AG879. Protein synthesis rates were determined as described in the Materials and Methods section and were initially expressed as trichloroacetic acid-insoluble CPM per milligram of protein. To facilitate pooling multiple assays for statistical analysis, data from individual assays were normalized to the synthesis rate in SFM-treated cultures (control) for each assay. Triplicate determination were averaged for each assay, and each assay was completed a total of 6 times. Assays were performed utilizing cells isolated from 5 different animals. Bars containing no letters in common are statistically different from one another (P < 0.01).
of target genes (Simental et al., 1991; Dehm and Tindall, 2007) . Additionally, new data emerging from cancer research indicate that the AR may be involved in cross talk with the EGFR and erbB2, although it is currently unknown whether this occurs in skeletal muscle cells (Cinar et al., 2005; Cai et al., 2009; Pignon et al., 2009 ). Testosterone has also been shown to initiate a quicker, nongenomic response through GPCR and members of the erbB receptor family to increase growth in both muscle and nonmuscle cell types (Lieberherr and Grosse, 1994; Benten et al., 1999; Estrada et al., 2003) . These data suggest that testosterone and its analogs are likely involved in the initiation of several different pathways. In the current study, we have utilized inhibitors to determine the necessity for active GPCR, MMP2/9, hbEGF, EGFR, erbB2, and IGF-1R to support TBA-mediated increases in protein synthesis rates and decreases in protein degradation rates of fused BSC cultures. Additionally, we have assessed the effect of TBA treatment on pAKT levels in fused BSC cultures.
In the present study, we identified that GPCR, MMP2/9, hbEGF, EGFR, erbB2, and IGF-1R are all involved in the ability of TBA to stimulate the protein synthesis rate in fused BSC cultures. Previous studies conducted in skeletal muscle cells have also found that testosterone is capable of activating GPCR (Estrada et al., 2003; Fu et al., 2012) . G protein-coupled receptors are capable of directly activating members of the erbB family, including EGFR and erbB2 (Chan et al., 2006; Figure 6 . Effect of inhibition of the epidermal growth factor receptor (EGFR) using a specific tyrosine kinase inhibitor, AG1478, and/or inhibition of the erbB2 receptor using a specific tyrosine kinase inhibitor, AG879, on trenbolone acetate (TBA), heparin-binding epidermal growth factor (hbEGF), or LR3-IGF-1 induced alterations in protein degradation rate in fused bovine satellite cell cultures. After 120 h, cultures were incubated with 3 H-phenylalanine overnight. Cultures were then placed in chase media for 4 h, then rinsed with Dulbecco's modified eagle medium. Cultures were then treated with 1% IGFBP-3 stripped swine serum (SSS) or with SSS plus 10 nM TBA, 5 ng/mL hbEGF, 25 ng/mL LR3-IGF-1, and/or 1 µM AG1478 and/or 1 µM AG879 overnight. Protein degradation rates were determined as described in the Materials and Methods section and were initially expressed as (TCA-soluble medium counts/total TCA-soluble, TCA-insoluble, and cellular material counts) × 100 in each well, where TCA = trenbolone acetate. To facilitate pooling multiple assays for statistical analysis, data from individual assays were normalized to the degradation rate in SSS-treated cultures (control) for each assay. Triplicate determinations were averaged for each assay, and each assay was completed a total of 3 times. Assays were performed utilizing cells isolated from 3 different animals. Bars containing no letters in common are statistically different (P < 0.01). Figure 5 . Effect of inhibition of the insulin-like growth factor-1 receptor (IGF-1R) using a specific tyrosine kinase inhibitor, AG1024, on trenbolone acetate (TBA), heparin-binding epidermal growth factor (hbEGF), or long arginine 3 insulin-like growth factor-1 (LR3-IGF-1) induced alterations in protein synthesis rate in fused bovine satellite cell cultures. After 144 h, cultures were treated with serum-free medium (SFM) or with SFM plus 10 nM TBA, 5 ng/ mL hbEGF, 25 ng/mL LR3-IGF-1, and/or 1 µM AG1024. Protein synthesis rates were determined as described in the Materials and Methods section and were initially expressed as trichloroacetic acid-insoluble CPM per milligram of protein. To facilitate pooling multiple assays for statistical analysis, data from individual assays were normalized to the synthesis rate in SFM-treated cultures (control) for each assay. Triplicate determinations were averaged for each assay, and each assay was completed a total of 5 times. Assays were performed utilizing cells isolated from 4 different animals. Bars containing no letters in common are statistically different (P < 0.01). Arora et al., 2008) . Furthermore, studies in nonmuscle cells demonstrate that GPCR are capable of transactivation of the EGFR utilizing a mechanism involving MMP cleavage and release of membrane-bound hbE-GF (Luttrell et al., 1999; Prenzel et al., 1999; Liu and Armant, 2004; Filardo and Thomas, 2005; Chantrain et al., 2006; Almendro et al., 2010) . The IGF-1R is also involved in TBA-mediated alterations in protein synthesis and degradation as treatment of fused BSC cultures with JB1, a competitive inhibitor of IGF-1 binding to the IGF-1R, suppresses the positive effects of TBA (Kamanga-Sollo et al., 2011) . Additionally, data from our lab as well as others indicate that expression of the EGFR mediates expression of the IGF-1R, demonstrating that there is likely cross talk between these 2 receptors (Riedemann et al., 2007; Reiter et al., 2014) . The present study along with data from other research groups strongly suggest that TBA-mediated increases in protein synthesis rate of fused BSC cultures are mediated, at least in part, through activation of GPCR that then activates MMP2/9, resulting in cleavage of hbEGF from the cell membrane, which then activates erbB2 and EGFR, resulting in changes in IGF-1R activity and expression.
Trenbolone acetate-mediated decreases in protein degradation rate appear to occur through a different mechanism than TBA-mediated increases in protein synthesis rate. Inhibition of GPCR, MMP2/9, hbEGF, IGF-1R, EGFR, or erbB2 separately elicited no effect on TBA-mediated decreases in protein degradation rate of fused BSC cultures, indicating that none of these components separately is involved in the mechanism through which TBA decreases protein degradation rate. However, when both the EGFR and erbB2 are inhibited concurrently, TBA is no longer able to decrease protein degradation rates in fused BSC cultures, suggesting that either the combined action of both the EGFR and erbB2 are involved in the ability of TBA to decrease protein degradation rates or that the 2 receptors have redundant functions so that if either receptor is functioning, TBA-mediated decreases in protein degradation will occur. Studies conducted in cancerous nonmuscle cell lines demonstrate that inhibition of both the EGFR and erbB2 decreases growth rates much more than inhibiting either receptor alone (Xia et al., 2002; Zhou and Brattain, 2005; Reid et al., 2007) .
Both proliferation of satellite cells and protein synthesis and degradation in developing muscle fibers play crucial roles in muscle growth and development in beef cattle (Allen et al., 1979; Campion, 1984; Owens et al., 1993) . Our previous studies and results of the current study indicate that GPCR are required to support TBAmediated increases in both proliferation of mononucleated satellite cells and protein synthesis rate in fused BSC, whereas TBA-mediated decreases in protein degradation rate in fused BSC appear to occur through a mechanism that does not involve GPCR Thornton et al., 2015) . Since GDPβS is a general inhibitor of GPCR (of which there are over 800 different specific receptors), it is possible that different GPCR are responsible for the effects of TBA on proliferation and protein synthesis (Katritch et al., 2012) . Nonetheless, we believe it is significant that TBA regulation of 2 dissimilar processes such as proliferation rate in unfused proliferating satellite cells and protein synthesis rate in fused BSC require GPCR while the effect of TBA on protein degradation rate in fused BSC does not require GPRC. Further Figure 7 . (A) Western immunoblot images of pAKT levels in fused cultures treated in Dulbecco's modified eagle medium (DMEM) and 5 ng/ mL heparin-binding epidermal growth factor (hbEGF) or 10 nM trenbolone acetate (TBA) or 25 ng/mL long arginine 3 insulin-like growth factor-1 (LR3-IGF-1) for 30 min. Cultures were grown as described in the Materials and Methods section for 144 h. Cultures were then rinsed once with DMEM, placed in DMEM for a 30-min deprivation period, and then placed into treatment media for an additional 30 min. After this treatment period, protein was collected and stored at −80°C. Later, proteins were separated on a 10% SDS-PAGE gel and then transferred to a nitrocellulose membrane. Membranes were blotted for pAKT (Cell Signaling, Danvers, MA, catalog number 2128), stripped and then blotted again for tubulin (Cell Signaling; catalog number 7074). Images were obtained using the C Digit Plus (LI-COR, Lincoln, NE). (B) Representative graph of pAKT levels in fused cultures treated in DMEM and 5 ng/mL hbEGF or 10 nM TBA or 25 ng/mL LR3-IGF-1 for 30 min. All values were normalized to the tubulin values. To facilitate pooling multiple assays for statistical analysis, data from individual assays were normalized to the pAKT levels in DMEM-treated cultures (control) for each assay. Results are reflective of the average of 8 different assays. Assays were performed utilizing cells isolated from 6 different animals. Bars containing no letters in common are statistically different (P < 0.01). studies are required to identify the intracellular signaling pathways activated by TBA to elicit the observed effects on these important parameters of muscle growth. The present study found that treatment of fused BSC cultures with TBA increases pAKT level, suggesting that the AKT pathway is involved in TBA-mediated effects on fused BSC. Many studies conducted in both humans and animals have shown that the AKT pathway is involved in the ability of testosterone to improve growth of skeletal muscle (Bassel-Duby and Olson, 2006; Sato et al., 2008; Blaauw et al., 2009; White et al., 2013) . However, this is the first evidence that the AKT pathway may be involved in TBA-mediated alterations in fused BSC cultures. Additional studies are required to further elucidate the role of specific intracellular signaling pathways on TBA-mediated proliferation in mononucleated BSC and on protein synthesis and degradation rates in fused BSC.
In summary, our results demonstrate that GPCR, MMP2/9, hbEGF, EGFR, erbB2, and IGF-1R are involved in TBA-mediated increases in protein synthesis rate of fused BSC cultures. This is consistent with our hypothesis that TBA activates GPCR that subsequently activate MMP2/9, resulting in proteolytic release of hbEGF that is then capable of activating the EGFR and erB2, which have a role in the expression and activity of IGF-1R. In contrast, it appears that this mechanism is not involved in TBA-mediated decreases in protein degradation rate in fused BSC cultures. However, our results suggest that the combined action of the EGFR and erbB2 is involved in the mechanism through which TBA decreases protein degradation rate. Furthermore, because TBA treatment increases pAKT levels in fused BSC cultures, the AKT pathway may also be involved in the TBA-mediated effects on bovine skeletal muscle growth. The exact role that each of these molecules has in protein turnover rates, especially the relationship between these molecules and the AR, requires further research.
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